心臟病學5 篇

影響力 1

Statement of Retraction: Long non-coding RNA lincRNA-erythroid prosurvival attenuates inflammation by enhancing myosin heavy chain 6 stability through recruitment of heterogeneous nuclear ribonucleoprotein L in myocardial infarction.

發表日期: 2026-12-01

Bioengineered

MediLens 收錄日: 2026-05-23

(No abstract provided)

在PubMed上閱讀

影響力 2

Dynamic regulation of the 'mitochondria‑immune axis' in myocardial infarction: Molecular mechanisms driving macrophage polarization through energy metabolism disorders (Review).

發表日期: 2026-07-01

Molecular medicine reports

MediLens 收錄日: 2026-05-23

Myocardial infarction (MI) involves not only cardiomyocyte necrosis but also immune system activation and mitochondrial energy metabolism issues. Mitochondrial damage leads to impaired ATP production and excess release of metabolites, promoting M1 macrophage polarization and secondary myocardial ...

在PubMed上閱讀

影響力 2

Targeting lipophagy in atherosclerosis: Molecular mechanisms, pathogenesis and therapeutic interventions (Review).

發表日期: 2026-07-01

Molecular medicine reports

MediLens 收錄日: 2026-05-23

This review discusses the role of lipophagy in atherosclerosis (AS), highlighting its importance in lipid homeostasis and plaque stabilization. It summarizes key regulatory networks and the effects of lipophagy on various cell types involved in AS, including macrophages, vascular smooth muscle ce...

在PubMed上閱讀

影響力 3

SREBP1 Transactivation of NHE3 Impairs Cardiac Contraction and Aggravates Heart Failure.

發表日期: 2026-05-22

Circulation

MediLens 收錄日: 2026-05-23

This study investigates the role of SREBP1 in heart failure with reduced ejection fraction (HFrEF), highlighting its activation in human and mouse hearts. The findings reveal that SREBP1 contributes to impaired cardiac contractility and dysregulated calcium handling through the transactivation of...

在PubMed上閱讀

影響力 2

Drug-Induced Noninfectious Myocarditis/Pericarditis: A Real-World Pharmacovigilance Study Using the FAERS Database.

發表日期: 2026-05-22

Cardiovascular toxicology

MediLens 收錄日: 2026-05-23

This study identifies drugs associated with drug-induced noninfectious myocarditis/pericarditis by analyzing 21,422 adverse event reports from the FDA database. A total of 953 drugs were suspected, with clozapine, nivolumab, and pembrolizumab being the most frequently reported. The study highligh...

在PubMed上閱讀

醫學研究趨勢

心臟病學5 篇

Statement of Retraction: Long non-coding RNA lincRNA-erythroid prosurvival attenuates inflammation by enhancing myosin heavy chain 6 stability through recruitment of heterogeneous nuclear ribonucleoprotein L in myocardial infarction.

Dynamic regulation of the 'mitochondria‑immune axis' in myocardial infarction: Molecular mechanisms driving macrophage polarization through energy metabolism disorders (Review).

Targeting lipophagy in atherosclerosis: Molecular mechanisms, pathogenesis and therapeutic interventions (Review).

SREBP1 Transactivation of NHE3 Impairs Cardiac Contraction and Aggravates Heart Failure.

Drug-Induced Noninfectious Myocarditis/Pericarditis: A Real-World Pharmacovigilance Study Using the FAERS Database.

獲取個人化每日摘要